tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market

Neuphoria Therapeutics (NEUP) Income Statement

Compare
303 Followers

Neuphoria Therapeutics Income Statement

Last quarter (Q1 2026), Neuphoria Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Neuphoria Therapeutics's net income was $-14.99M. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 23.95M$ 0.00$ 0.00-$ 0.00
Gross Profit
$ 22.94M$ -992.56K$ -671.42K$ 0.00$ -1.69M
Operating Expenses
$ 24.67M$ 25.79M$ 21.58M$ 27.71M$ 11.26M
Depreciation and Amortization
$ 1.01M$ 992.56K$ 671.42K$ 1.17M$ 1.69M
EBITDA
$ -268.02K$ -22.33M$ -21.54M$ -28.03M$ -6.63M
Operating Income
$ -1.73M$ -26.79M$ -22.26M$ -28.60M$ -12.95M
Other Income/Expenses
$ 445.56K$ 3.46M$ 39.87K--
Pretax Income
$ -1.28M$ -23.32M$ -22.22M$ -29.24M$ -9.76M
Net Income
$ -565.77K$ -23.19M$ -21.65M$ -22.94M$ -8.65M
Per Share Metrics
Basic EPS
$ -0.23$ -0.10$ -0.17$ -0.13$ -0.10
Diluted EPS
$ -0.23$ -0.10$ -0.17$ -0.13$ -0.10
Weighted Average Shares Outstanding
1.62M 149.80M 122.39M 112.78M 65.00M
Weighted Average Shares Outstanding (Diluted)
1.62M 149.80M 122.39M 112.78M 65.00M
Currency in USD

Neuphoria Therapeutics Earnings and Revenue History